Multiplex Assay Market by Type (Nucleic Acid-Based Multiplex Assays, Protein-Based Multiplex Assays, and Others), Product (Multiplex Assay Reagents & Consumables, Multiplex Assay Accessories & Instruments, and Multiplex Assay Software & Services), Technology (Multiplex PCR, Multiplex Protein Microarray, and Others), Application (Companion Diagnostics, Research & Development (Drug Development and Biomarker Discovery & Validation), and Clinical Diagnostics) and End User (Hospitals, Clinical Laboratories, Research Institutes, and Pharmaceuticals & Biotechnological Companies): Global Opportunity Analysis and Industry Forecast, 2019–2026
|
A01591
|
Pages: 289
|
Jul
2019 |
5383 Views
|
||
|
Author(s) :
Sohail Sheikh, Kavita Joshi
, Onkar Sumant
|
Tables: 161
|
Charts: 39
|
Formats*:
|
Multiplex Assay Market Outlook - 2026
The global Multiplex Assay Market size accounted for $73.2 million in 2018, and is expected to reach $123.1 million by 2026, growing at a CAGR of 6.6% from 2019 to 2026.
Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others.
Get more information on this report : Request Sample Pages
The Multiplex Assay Market is witnessing significant growth, owing to increase in R&D activities in the pharmaceutical sector for the treatment of several diseases. These assays are used in clinical trials as they decrease the cost of research & manual labor and increase the efficiency of experiments and therapies. In addition, they offer easier & faster analysis of diseases, and are automated, thus fueling the Multiplex Assay Market growth. However, high capital investment and dearth of skilled labors are the major factors that hinder the market growth.
In the report, the global Multiplex Assay Market is studied based on type, product, technology, application, end user, and region. On the basis of type, the market is divided into nucleic acid-based, protein-based multiplex assays, and others. By product, it is classified into multiplex assay reagents & consumables, multiplex assay instruments & accessories, and multiplex assay software & services. Depending on technology, it is categorized into nucleic acid-based, protein-based multiplex assays, and others. The applications covered in the study include companion diagnostics, research & development, clinical diagnostics, and others. As per end user, the market is segregated into hospitals, clinical laboratories, research institutes, and pharmaceuticals & biotechnological companies. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Get more information on this report : Request Sample Pages
Type segment review
Based on type, the Multiplex Assay Market is classified into nucleic acid-based multiplex assays, protein-based multiplex assays, and others. The protein-based assay segment was the largest contributor to the Multiplex Assay Market, and is expected to grow with the highest rate during the forecast period. Rise in adoption of protein-based multiplex assays for analyzing unknown proteins and their functions simultaneously and precisely is the key trend that drives the market growth. Moreover, nucleic acid-based multiplex assay segment is anticipated to grow at the highest rate during the forecast period. This is attributed to increased use of nucleic acids in clinical diagnostics, owing to their high specificity, ease with which they can be configured to detect almost any target, minimal usage of quantities of sample, and their ability to be automated. In addition, increased use of molecular tests developed to diagnose diseases, including tests to detect disease-causing pathogens as well as human genetic or protein markers indicative of disease such as cancer and genetic markers for predisposition to disease, contributes toward the growth of the nucleic acid-based assays segment.
Get more information on this report : Request Sample Pages
Product segment review
By product, the multiplex assay industry is segregated into reagents & consumables, instruments & accessories, and software & services. The multiplex assay consumables segment held the largest market share in 2018, owing to rise in demand for assay kits along with increase in number of diagnostic tests & bulk purchase of consumables.
Get more information on this report : Request Sample Pages
Region segment review
Region wise, the Multiplex Assay Market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2018, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to increase in funding by government agencies and rise in focus to develop novel drug and biomarkers in this region. However, as per Multiplex Assay Market forecast, Asia-Pacific is projected to register the highest growth rate from 2018 to 2025. This is attributed to rise in investment by the government as well as private companies for research activities. In addition, increase in penetrance of key players, including Thermo Fisher, Illumina, Inc., and others in this region fuels the growth of the market.
The major players operating in the global Multiplex Assay Market are Luminex Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Becton, Dickinson and Company, Abcam PLC, Seegene Inc., Meso Scale Diagnostics LLC, and Randox Laboratories Ltd. These players adopted product launch, collaboration, and merger & acquisition as their key developmental strategies. The other players (not included in the report) include Merck, Agilent Technologies, Quanterix, and Olink.
Key Benefits for Multiplex Assay Market:
- The study provides an in-depth analysis of the global Multiplex Assay Market share with the current trends and future estimations to elucidate the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the market is provided.
- A comprehensive quantitative Multiplex Assay Market analysis is provided from 2018 to 2026 to assist stakeholders to capitalize on the prevailing opportunities.
- An extensive analysis of the key segments of the industry helps to understand the global Multiplex Assay Market trends.
- Key players and their strategies are provided to understand the competitive outlook of the industry.
Multiplex Assay Market Segments:
By Type
- Nucleic Acid-based Multiplex Assays
- Protein-based Multiplex Assays
- Others
By Product
- Multiplex Assay Reagents & Consumables
- Multiplex Assay Instruments & Accessories
- Multiplex Assay Software & Services
By Technology
- Multiplex PCR
- Multiplex Protein Microarray
- Others
By Application
- Companion Diagnostics
- Research & Development
- Clinical Diagnostics
End User
- Hospitals
- Clinical Laboratories
- Research Institutes
- Pharmaceuticals & Biotechnological Companies
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- France
- Germany
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Saudi Arabia
- South Africa
- Brazil
- Rest of LAMEA
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of buyers
3.3.2. Low bargaining power of suppliers
3.3.3. Moderate threat of substitutes
3.3.4. Low threat of new entrants
3.3.5. Moderate competitive rivalry
3.4. Market share analysis, 2018
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in R&D activities & governmental funding
3.5.1.2. Surge in adoption of multiplex assays to reduce operation costs
3.5.1.3. Rise in adoption of personalized medicines
3.5.2. Restraint
3.5.2.1. Lack of skilled labor/healthcare professionals
3.5.3. Opportunity
3.5.3.1. Various growth opportunities in emerging economies
CHAPTER 4: MULTIPLEX ASSAYS MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Nucleic acid-based multiplex assays
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market share analysis, by country
4.3. Protein-based multiplex assays
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market share analysis, by country
4.4. Others
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market share analysis, by country
CHAPTER 5: MULTIPLEX ASSAYS MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Multiplex assays reagents & consumables
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast
5.2.3. Market share analysis, by country
5.3. Multiplex assays instruments & accessories
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast
5.3.3. Market share analysis, by country
5.4. Multiplex assay software & services
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast
5.4.3. Market share analysis, by country
CHAPTER 6: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY
6.1. Overview
6.1.1. Market size and forecast
6.2. Multiplex PCR
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast
6.2.3. Market share analysis, by country
6.3. Multiplex protein microarray
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast
6.3.3. Market share analysis, by country
6.3.4. Immunohistochemistry
6.3.4.1. Market size and forecast
6.4. Other technologies
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast
6.4.3. Market share analysis, by country
CHAPTER 7: MULTIPLEX ASSAYS MARKET, BY APPLICATION
7.1. Overview
7.1.1. Market size and forecast
7.2. Companion diagnostics
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast
7.2.3. Market share analysis, by country
7.3. Research & development
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast
7.3.3. Market share analysis, by country
7.4. Clinical diagnostics
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast
7.4.3. Market share analysis, by country
CHAPTER 8: MULTIPLEX ASSAYS MARKET, BY END USER
8.1. Overview
8.1.1. Market size and forecast
8.2. Hospitals
8.2.1. Key market trends, growth factors, and opportunities
8.2.2. Market size and forecast
8.2.3. Market share analysis, by country
8.3. Clinical laboratories
8.3.1. Key market trends, growth factors, and opportunities
8.3.2. Market size and forecast
8.3.3. Market share analysis, by country
8.4. Research institutes
8.4.1. Key market trends, growth factors, and opportunities
8.4.2. Market size and forecast
8.4.3. Market share analysis, by country
8.5. Pharmaceuticals & biotechnology companies
8.5.1. Key market trends, growth factors, and opportunities
8.5.2. Market size and forecast
8.5.3. Market share analysis, by country
CHAPTER 9: MULTIPLEX ASSAYS MARKET, BY REGION
9.1. Overview
9.1.1. Market size and forecast
9.2. North America
9.2.1. Key market trends and opportunities
9.2.2. Market size and forecast, by country
9.2.3. Market size and forecast, by type
9.2.4. Market size and forecast, by product
9.2.5. Market size and forecast, by technology
9.2.6. Market size and forecast, by application
9.2.7. Market size and forecast, by end user
9.2.8. U.S.
9.2.8.1. U.S. market size and forecast, by type
9.2.8.2. U.S. market size and forecast, by product
9.2.8.3. U.S. market size and forecast, by technology
9.2.8.4. U.S. market size and forecast, by application
9.2.8.5. U.S. market size and forecast, by end user
9.2.9. Canada
9.2.9.1. Canada market size and forecast, by type
9.2.9.2. Canada market size and forecast, by product
9.2.9.3. Canada market size and forecast, by technology
9.2.9.4. Canada market size and forecast, by application
9.2.9.5. Canada market size and forecast, by end user
9.2.10. Mexico
9.2.10.1. Mexico market size and forecast, by type
9.2.10.2. Mexico market size and forecast, by product
9.2.10.3. Mexico market size and forecast, by technology
9.2.10.4. Mexico market size and forecast, by application
9.2.10.5. Mexico market size and forecast, by end user
9.3. Europe
9.3.1. Key growth factors and opportunities
9.3.2. Market size and forecast, by country
9.3.3. Market size and forecast, by type
9.3.4. Market size and forecast, by product
9.3.5. Market size and forecast, by technology
9.3.6. Market size and forecast, by application
9.3.7. Market size and forecast, by end user
9.3.8. Germany
9.3.8.1. Germany market size and forecast, by type
9.3.8.2. Germany market size and forecast, by product
9.3.8.3. Germany market size and forecast, by technology
9.3.8.4. Germany market size and forecast, by application
9.3.8.5. Germany market size and forecast, by end user
9.3.9. France
9.3.9.1. France market size and forecast, by type
9.3.9.2. France market size and forecast, by product
9.3.9.3. France market size and forecast, by technology
9.3.9.4. France market size and forecast, by application
9.3.9.5. France market size and forecast, by end user
9.3.10. UK
9.3.10.1. UK market size and forecast, by type
9.3.10.2. UK market size and forecast, by product
9.3.10.3. UK market size and forecast, by technology
9.3.10.4. UK market size and forecast, by application
9.3.10.5. UK market size and forecast, by end user
9.3.11. Italy
9.3.11.1. Italy market size and forecast, by type
9.3.11.2. Italy market size and forecast, by product
9.3.11.3. Italy market size and forecast, by technology
9.3.11.4. Italy market size and forecast, by application
9.3.11.5. Italy market size and forecast, by end user
9.3.12. Spain
9.3.12.1. Spain market size and forecast, by type
9.3.12.2. Spain market size and forecast, by product
9.3.12.3. Spain market size and forecast, by technology
9.3.12.4. Spain market size and forecast, by application
9.3.12.5. Spain market size and forecast, by end user
9.3.13. Rest of Europe
9.3.13.1. Rest of Europe market size and forecast, by type
9.3.13.2. Rest of Europe market size and forecast, by product
9.3.13.3. Rest of Europe market size and forecast, by technology
9.3.13.4. Rest of Europe market size and forecast, by application
9.3.13.5. Rest of Europe market size and forecast, by end user
9.4. Asia-Pacific
9.4.1. Key growth factors and opportunities.
9.4.2. Market size and forecast, by country
9.4.3. Market size and forecast, by type
9.4.4. Market size and forecast, by product
9.4.5. Market size and forecast, by technology
9.4.6. Market size and forecast, by application
9.4.7. Market size and forecast, by end user
9.4.8. Japan
9.4.8.1. Japan market size and forecast, by type
9.4.8.2. Japan market size and forecast, by product
9.4.8.3. Japan market size and forecast, by technology
9.4.8.4. Japan market size and forecast, by application
9.4.8.5. Japan market size and forecast, by end user
9.4.9. China
9.4.9.1. China market size and forecast, by type
9.4.9.2. China market size and forecast, by product
9.4.9.3. China market size and forecast, by technology
9.4.9.4. China market size and forecast, by application
9.4.9.5. China market size and forecast, by end user
9.4.10. India
9.4.10.1. India market size and forecast, by type
9.4.10.2. India market size and forecast, by product
9.4.10.3. India market size and forecast, by technology
9.4.10.4. India market size and forecast, by application
9.4.10.5. India market size and forecast, by end user
9.4.11. Rest of Asia-Pacific
9.4.11.1. Rest of Asia-Pacific market size and forecast, by type
9.4.11.2. Rest of Asia-Pacific market size and forecast, by product
9.4.11.3. Rest of Asia-Pacific market size and forecast, by technology
9.4.11.4. Rest of Asia-Pacific market size and forecast, by application
9.4.11.5. Rest of Asia-Pacific market size and forecast, by end user
9.5. LAMEA
9.5.1. Key growth factors and opportunities
9.5.2. Market size and forecast, by country
9.5.3. Market size and forecast, by type
9.5.4. Market size and forecast, by product
9.5.5. Market size and forecast, by technology
9.5.6. Market size and forecast, by application
9.5.7. Market size and forecast, by end user
9.5.8. Brazil
9.5.8.1. Brazil market size and forecast, by type
9.5.8.2. Brazil market size and forecast, by product
9.5.8.3. Brazil market size and forecast, by technology
9.5.8.4. Brazil market size and forecast, by application
9.5.8.5. Brazil market size and forecast, by end user
9.5.9. Saudi Arabia
9.5.9.1. Saudi Arabia market size and forecast, by type
9.5.9.2. Saudi Arabia market size and forecast, by product
9.5.9.3. Saudi Arabia market size and forecast, by technology
9.5.9.4. Saudi Arabia market size and forecast, by application
9.5.9.5. Saudi Arabia market size and forecast, by end user
9.5.10. South Africa
9.5.10.1. South Africa market size and forecast, by type
9.5.10.2. South Africa market size and forecast, by product
9.5.10.3. South Africa market size and forecast, by technology
9.5.10.4. South Africa market size and forecast, by application
9.5.10.5. South Africa market size and forecast, by end user
9.5.11. Rest of LAMEA
9.5.11.1. Rest of LAMEA market size and forecast, by type
9.5.11.2. Rest of LAMEA market size and forecast, by product
9.5.11.3. Rest of LAMEA market size and forecast, by technology
9.5.11.4. Rest of LAMEA market size and forecast, by application
9.5.11.5. Rest of LAMEA market size and forecast, by end user
CHAPTER 10: COMPANY PROFILES
10.1. ABCAM PLC.
10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Operating business segments
10.1.4. Product portfolio
10.1.5. Business performance
10.2. BECTON, DICKINSON AND COMPANY
10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Operating business segments
10.2.4. Product portfolio
10.2.5. Business performance
10.3. MESO SCALE DIAGNOSTICS, LLC.
10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Product portfolio
10.3.5. Key strategic moves and developments
10.4. RANDOX LABORATORIES LTD.
10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Operating business segments
10.4.4. Product portfolio
10.5. SEEGENE INC.
10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Product Portfolio
10.5.5. Business performance
10.5.6. Key strategic moves and developments
10.6. BIO-RAD LABORATORIES, INC.
10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Product Portfolio
10.6.5. Business performance
10.7. ILLUMINA, INC.
10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Product portfolio
10.7.5. Business performance
10.8. QIAGEN N.V.
10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Operating business segments
10.8.4. Business performance
10.8.5. Key strategic moves and developments
10.9. THERMO FISHER SCIENTIFIC, INC.
10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Product portfolio
10.9.5. Business performance
10.10. LUMINEX CORPORATION
10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Operating business segments
10.10.4. Product portfolio
10.10.5. Business performance
LIST OF TABLES
TABLE 01. GLOBAL MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 02. NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2018-2026 ($MILLION)
TABLE 03. PROTEIN-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2018-2026 ($MILLION)
TABLE 04. OTHER MULTIPLEX ASSAYS MARKET, BY REGION, 2018-2026 ($MILLION)
TABLE 05. MULTIPLEX ASSAY REAGENTS & CONSUMABLES MARKET, BY REGION, 2018-2026 ($MILLION)
TABLE 06. MULTIPLEX ASSAY REAGENTS & CONSUMABLES MARKET, BY REGION, 2018-2026 ($MILLION)
TABLE 07. MULTIPLEX ASSAY INSTRUMENTS & ACCESSORIES MARKET, BY REGION, 2018-2026 ($MILLION)
TABLE 08. MULTIPLEX ASSAY SOFTWARE AND SERVICES MARKET, BY REGION, 2018-2026 ($MILLION)
TABLE 09. GLOBAL MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 10. MULTIPLEX PCR ASSAYS MARKET, BY REGION, 2018-2026 ($MILLION)
TABLE 11. MULTIPLEX ASSAYS MARKET FOR PROTEIN MICROARRAY/ IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2026 ($MILLION)
TABLE 12. IMMUNOHISTOCHEMISTRY (IHC) MULTIPLEX ASSAYS MARKET, KEY PLAYERS
TABLE 13. MULTIPLEX ASSAYS MARKET FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2026 ($MILLION)
TABLE 14. MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2018-2026 ($MILLION)
TABLE 15. MULTIPLEX ASSAY REAGENTS & CONSUMABLES MARKET, BY REGION, 2018-2026 ($MILLION)
TABLE 16. MULTIPLEX ASSAYS MARKET FOR COMPANION DIAGNOSTICS, BY REGION, 2018-2026 ($MILLION)
TABLE 17. MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2018-2026 ($MILLION)
TABLE 18. MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2018-2026 ($MILLION)
TABLE 19. GLOBAL MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 20. MULTIPLEX ASSAYS MARKET FOR HOSPITALS, BY REGION, 2018-2026 ($MILLION)
TABLE 21. MULTIPLEX ASSAYS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2018-2026 ($MILLION)
TABLE 22. MULTIPLEX ASSAYS MARKET FOR RESEARCH INSTITUTES, BY REGION, 2018-2026 ($MILLION)
TABLE 23. MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2026 ($MILLION)
TABLE 24. MULTIPLEX ASSAYS MARKET, BY REGION, 2018-2026 ($MILLION)
TABLE 25. NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 26. NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 27. NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018–2026 ($MILLION),
TABLE 28. NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 29. NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 30. NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 31. U.S. MULTIPLEX ASSAYS MARKET BY TYPE, 2018-2026 ($MILLION)
TABLE 32. U.S. MULTIPLEX ASSAYS MARKET BY PRODUCT, 2018-2026 ($MILLION)
TABLE 33. U.S. MULTIPLEX ASSAYS MARKET BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 34. U.S. MULTIPLEX ASSAYS MARKET BY APPLICATION, 2018-2026 ($MILLION)
TABLE 35. U.S. MULTIPLEX ASSAYS MARKET BY END USER, 2018-2026 ($MILLION)
TABLE 36. CANADA MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 37. CANADA MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 38. CANADA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 39. CANADA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 40. CANADA MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 41. MEXICO MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 42. MEXICO MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 43. MEXICO MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 44. MEXICO MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 45. MEXICO MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 46. EUROPE MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 47. EUROPE MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 48. EUROPE MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018–2026 ($MILLION),
TABLE 49. EUROPE MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 50. EUROPE MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 51. EUROPE MULTIPLEX ASSAYS MARKET, BY END USER 2018-2026 ($MILLION)
TABLE 52. GERMANY MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 53. GERMANY MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 54. GERMANY MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 55. GERMANY MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 56. GERMANY MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 57. FRANCE MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 58. FRANCE MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 59. FRANCE MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 60. FRANCE MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 61. FRANCE MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 62. U.K. MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 63. U.K. MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 64. U.K. MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 65. U.K. MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 66. U.K. MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 67. ITALY MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 68. ITALY MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 69. ITALY MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 70. ITALY MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 71. ITALY MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 72. SPAIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 73. SPAIN MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 74. SPAIN MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 75. SPAIN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 76. SPAIN MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 77. REST OF EUROPE MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 78. REST OF EUROPE MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 79. REST OF EUROPE MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 80. REST OF EUROPE MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 81. REST OF EUROPE MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 82. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 83. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 84. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018–2026 ($MILLION),
TABLE 85. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 86. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 87. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 88. JAPAN MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 89. JAPAN MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 90. JAPAN MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 91. JAPAN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 92. JAPAN MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 93. CHINA MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 94. CHINA MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 95. CHINA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 96. CHINA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 97. CHINA MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 98. INDIA MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 99. INDIA MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 100. INDIA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 101. INDIA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 102. INDIA MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 103. REST OF ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 104. REST OF ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 105. REST OF ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 106. REST OF ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 107. REST OF ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 108. LAMEA MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 109. LAMEA MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 110. LAMEA MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018–2026 ($MILLION),
TABLE 111. LAMEA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 112. LAMEA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 113. LAMEA MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 114. BRAZIL MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 115. BRAZIL MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 116. BRAZIL MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 117. BRAZIL MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 118. BRAZIL MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 119. SAUDI ARABIA MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 120. SAUDI ARABIA MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 121. SAUDI ARABIA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 122. SAUDI ARABIA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 123. SAUDI ARABIA MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 124. SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 125. SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 126. SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 127. SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 128. SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 129. REST OF LAMEA MULTIPLEX ASSAYS MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 130. REST OF LAMEA MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 131. REST OF LAMEA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 132. REST OF LAMEA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 133. REST OF LAMEA MULTIPLEX ASSAYS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 134. ABCAM PLC.: COMPANY SNAPSHOT
TABLE 135. ABCAM PLC.: OPERATING SEGMENTS
TABLE 136. ABBVIE PLC.: PRODUCT PORTFOLIO
TABLE 137. BECTON, DICKINSON AND COMPANY: SNAPSHOT
TABLE 138. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 139. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 140. MESO SCALE TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 141. MSD: OPERATING SEGMENTS
TABLE 142. MSD: PRODUCT PORTFOLIO
TABLE 143. RANDOX: COMPANY SNAPSHOT
TABLE 144. RANDOX OPERATING SEGMENTS
TABLE 145. RANDOX: PRODUCT PORTFOLIO
TABLE 146. SEEGENE: COMPANY SNAPSHOT
TABLE 147. SEEGENE: OPERATING SEGMENTS
TABLE 148. BIO-RAD: COMPANY SNAPSHOT
TABLE 149. BIO-RAD: OPERATING SEGMENTS
TABLE 150. BIO-RAD: PRODUCT PORTFOLIO
TABLE 151. ILLUMINA: COMPANY SNAPSHOT
TABLE 152. ILLUMINA: OPERATING SEGMENTS
TABLE 153. ILLUMINA: PRODUCT PORTFOLIO
TABLE 154. QIAGEN: COMPANY SNAPSHOT
TABLE 155. QIAGEN: NET SALES, 2016–2018 ($MILLION)
TABLE 156. THERMO FISHER: COMPANY SNAPSHOT
TABLE 157. THERMO FISHER: OPERATING SEGMENTS
TABLE 158. THERMO FISHER: PRODUCT PORTFOLIO
TABLE 159. LUMINEX CORPORATION: COMPANY SNAPSHOT
TABLE 160. LUMINEX CORPORATION: OPERATING SEGMENTS
TABLE 161. LUMINEX CORPORATION: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. GLOBAL MULTIPLEX ASSAYS, MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. MARKET SHARE ANALYSIS, 2018
FIGURE 04. DRIVERS, RESTRAINT, AND OPPORTUNITY, GLOBAL MULTIPLEX ASSAYS MARKET
FIGURE 05. COMPARATIVE SHARE ANALYSIS OF NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 06. COMPARATIVE SHARE ANALYSIS OF PROTEIN-BASED MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 07. COMPARATIVE SHARE ANALYSIS OF OTHER MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 08. COMPARATIVE SHARE ANALYSIS OF REAGENTS & CONSUMABLES MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF INSTRUMENTS & ACCESSORIES MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF SOFTWARE AND SERVICES MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX PCR ASSAYS MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX PROTEIN MICROARRAY/ IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF OTHER MULTIPLEX ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF COMPANION DIAGNOSTICS MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF RESEARCH & DEVELOPMENT MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CLINICAL DIAGNOSTICS MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAYS MARKET, FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAYS MARKET, FOR CLINICAL LABORATORIES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAYS MARKET, FOR RESEARCH INSTITUTES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAYS MARKET, FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 21. ABCAM PLC.: NET SALES, 2016–2018 ($MILLION)
FIGURE 22. ABCAM PLC.: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 23. BD: NET SALES, 2016–2018 ($MILLION)
FIGURE 24. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 25. BECTON, DICKINSON AND COMPANY REVENUE SHARE BY REGION, 2018 (%)
FIGURE 26. SEEGENE: NET SALES, 2016–2018 ($MILLION)
FIGURE 27. BIO-RAD: NET SALES, 2016–2018 ($MILLION)
FIGURE 28. BIO-RAD: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 29. BIO-RAD: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 30. ILLUMINA: NET SALES, 2016–2018 ($MILLION)
FIGURE 31. ILLUMINA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 32. REVENUE SHARE BY REGION, 2018 (%)
FIGURE 33. QIAGEN: REVENUE SHARE BY PRODUCT, 2018 (%)
FIGURE 34. QIAGEN: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 35. TERUMO: NET SALES, 2016–2018 ($MILLION)
FIGURE 36. THERMO FISCHER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 37. THERMO FISCHER: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 38. LUMINEX CORPORATION: NET SALES, 2016–2018 ($MILLION)
FIGURE 39. LUMINEX CORPORATION: REVENUE SHARE BY REGION, 2018 (%)
The utilization of multiplex assays for diagnostic purposes in hospitals and R&D is significantly increasing, owing to surge in incidence of chronic diseases such as cancer, Alzheimer’s disease, and others. This is attributed to the fact that multiplex assays offer several advantages such as accurate output for analyzing multiple analytes in a shorter span of time as compared to the conventional mode of assays. In addition, these assays increase the efficiency of experiments in clinical laboratories for biomarker validation and diagnosis & treatment of diseases. Furthermore, recent innovations and constant developments in this field have fueled the adoption of this assays across various applications. For instance, in 2018, Seegene developed world’s first multiplex MDx assays with artificial intelligence (AI) system. The performance of assays developed by using AI is better as compared to manually developed assays.
Moreover, multiplex assays are used prominently for protein-based assays, due to increase in R&D activities to introduce novel drug therapies. In addition, bead-based multiplex assays are used frequently, as they have a larger surface area than planar-based assays, and hence offer a wide range of targets for the detection of proteins and nucleic acids. Increase in economic strength of the developing nations such as China, India, Indonesia, Thailand, and others and rise in healthcare expenditure & government funding for R&D are expected to drive the market growth during the forecast period. North America and Europe are expected to dominate the market for multiplex assays during the forecast period, while emerging countries in Asia-Pacific and Latin America are expected to offer significant growth opportunities.
Download Sample
Purchase Full Report of
Multiplex Assay Market
- Online Only
- $3,565
- Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
- $3,961
- Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
- $5,540
- Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
- $6,654
- Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF - $9,280
- Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $0.00
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading instantly.
Buy Now
This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.